펩타이드 의약품 API 수탁제조 시장 보고서(2035년)

Peptide therapeutics contract API manufacturing refers to outsourced, specialized services that produce peptide-based active pharmaceutical ingredients for drug developers and pharmaceutical companies. These services typically include solid-phase or liquid-phase peptide synthesis, purification, characterization, scale-up, and GMP-compliant manufacturing to meet regulatory requirements for clinical and commercial use. The primary purpose of contract peptide API manufacturing is to enable reliable, high-quality, and scalable production of peptide drugs without requiring in-house manufacturing infrastructure.

The peptide therapeutics contract API manufacturing market consists of sales, by entities (organizations, sole traders, or partnerships), of peptide therapeutics contract API manufacturing that used by pharmaceutical companies during drug development and commercial production. During the preclinical and clinical phases, peptide APIs are used for early research, toxicology testing, and clinical trial supplies.

The global peptide therapeutics contract active pharmaceutical ingredient (API) manufacturing market grew from $1,967.8 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 7.0%.

Expansion Of Clinical Trials And Robust Therapeutic Pipeline

During the historic period, the peptide therapeutics contract active pharmaceutical ingredient (API) manufacturing market was significantly driven by the expansion of clinical trials and robust therapeutic pipeline. As pharmaceutical and biotechnology companies advanced a growing number of peptide candidates into preclinical and clinical evaluation, the need for consistent, GMP-compliant peptide APIs intensified across multiple trial phases. Internal manufacturing capabilities were often insufficient to support parallel programs, varying batch sizes, and frequent process adjustments required during clinical progression. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported that the total number of clinical trials initiated in the UK rose from 411 in 2022 to 426 in 2023. Therefore, the peptide therapeutics contract active pharmaceutical ingredient (API) manufacturing market was significantly driven by the expansion of clinical trials and robust therapeutic pipeline.

Digitalization, Cloud, Big Data And Cybersecurity

Digitalization is reshaping operational and quality management frameworks across the peptide therapeutics contract API manufacturing landscape. Cloud-based platforms and big data analytics are being deployed to integrate R&D data, manufacturing records, and quality documentation across global facilities. As manufacturers increasingly handle proprietary molecular sequences and sensitive clinical data, cybersecurity has become a strategic priority, with robust digital safeguards implemented to protect intellectual property, ensure data integrity, and meet stringent regulatory expectations. For instance, in May 2025, Lonza, a Switzerland-based global contract development and manufacturing organization, announced the launch of its new Design2Optimize platform aimed at streamlining active pharmaceutical ingredient (API) process development by leveraging a model-based design of experiments (DoE) and predictive modelling to reduce the number of physical experiments required, enhance process optimization, and accelerate timelines for peptide API process development and manufacturing in the peptide therapeutics contract active pharmaceutical ingredient market.

The global peptide therapeutics contract active pharmaceutical ingredient (API) manufacturing market is concentrated, with a large players dominating across major regions. The top 10 competitors in the market made up 47.8% of the total market in 2024.

Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global peptide therapeutics contract API manufacturing market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for peptide therapeutics contract API manufacturing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peptide therapeutics contract API manufacturing market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider peptide therapeutics contract API manufacturing market; and compares it with other markets.

The report covers the following chapters

• Introduction And Market Characteristics Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products, supply chain and market attractiveness scoring and analysis.
• Key Trends Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Growth Analysis And Strategic Analysis Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
• Regional And Country Analysis Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
• Market Segmentation Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by scale of operation, by synthesis method and by enterprise type in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
• Regional Market Size And Growth Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking Briefs on the financials comparison between major players in the market.
• Competitive Dashboard Briefs on competitive dashboard of major players.
• Key Mergers And Acquisitions Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Recent Developments Information on recent developments in the market covered in the report.
• Market Opportunities And Strategies-Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations-This section includes recommendations for peptide therapeutics contract API manufacturing providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.

Appendix This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report

Markets Covered:

• 1) By Scale Of Operation: Preclinical Or Clinical; Commercial
• 2) By Synthesis Method: Non Chemical Synthesis; Chemical Synthesis
• 3) By Enterprise Type: Large Enterprise; Small And Medium Enterprises
• Countries: China; Australia; India; Indonesia; Japan; South Korea; Taiwan; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa; South East Asia
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; peptide therapeutics contract API manufacturing indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Dashboard

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market Definition And Segmentations
• 6.4 Market Segmentation By Scale Of Operation (Preclinical Or Clinical And Commercial)
• 6.5 Market Segmentation By Synthesis Method (Non-Chemical Synthesis And Chemical Synthesis)
• 6.6 Market Segmentation By Enterprise Type (Large Enterprise And Small And Medium Enterprises)

7 Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Overview Of Key Products/Services

8 Global Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market Attractiveness Scoring And Analysis

• 8.1 Overview Of Market Attractiveness Framework
• 8.2 Quantitative Scoring Methodology
• 8.3 Market Attractiveness Scoring And Interpretation
• 8.4 Factor-Wise Evaluation
  • 8.4.1 Strategic Implications And Recommendations

9 Major Market Trends

• 9.1 Key Technologies & Future Trends
  • 9.1.1 Digitalization, Cloud, Big Data And Cybersecurity
  • 9.1.2 Sustainability, Climate Tech And Circular Economy
  • 9.1.3 Industry 4.0 And Intelligent Manufacturing
  • 9.1.4 Artificial Intelligence And Autonomous Intelligence
  • 9.1.5 Biotechnology, Genomics And Precision Medicine
• 9.2 Major Trends
  • 9.2.1 Expansion Of Flexible Peptide API Manufacturing Capabilities To Support Preclinical And Clinical Development Pipelines
  • 9.2.2 Scaling Of Commercial-Grade Peptide API Manufacturing Infrastructure To Meet Growing Global Therapeutic Demand
  • 9.2.3 Adoption Of Integrated End-To-End Peptide API Manufacturing Platforms To Improve Speed And Quality
  • 9.2.4 Advancement Of High-Purity Solid-Phase Peptide Synthesis (SPPS) For Complex Therapeutic Molecules
  • 9.2.5 Increasing Use Of Hybrid Peptide Synthesis Approaches Combining Chemical And Non-Chemical Methods
  • 9.2.6 Strengthening Of Good Manufacturing Practice (GMP) Compliant Peptide API Production For Late-Stage And Commercial Supply

10 Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market - Macro Economic Scenario

• 10.1 Impact of Interest Rate Fluctuations
• 10.2 Impact of Inflationary Pressures
• 10.3 Impact of Geopolitical Dynamics On Supply Chains
• 10.4 Impact of the COVID-19 Pandemic And Recovery
• 10.5 Strategic Insights And Future Outlook

11 Supply Chain Impact from Tariff War and Trade Protectionism

12 Global Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Pipeline Analysis

13 Global Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Growth Analysis And Strategic Analysis Framework

• 13.1 Global Peptide Therapeutics Contract API Manufacturing PESTEL Analysis
  • 13.1.1 Political
  • 13.1.2 Economic
  • 13.1.3 Social
  • 13.1.4 Technological
  • 13.1.5 Environmental
  • 13.1.6 Legal
• 13.2 Analysis Of End Users
  • 13.2.1 Large Pharmaceutical Companies
  • 13.2.2 Virtual And Asset-Light Drug Developers
  • 13.2.3 Contract Development And Manufacturing Organizations (CDMOs)
  • 13.2.4 Academic Research Institutes And Non-Profit Research Organizations
  • 13.2.5 Other End Users

14 Global Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market Size And Growth Analysis

• 14.1 Historic Market Growth, 2020 - 2025, Value ($ Million)
  • 14.1.1 Market Drivers 2020 - 2025
  • 14.1.2 Market Restraints 2020 - 2025
• 14.2 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
• 14.3 Forecast Growth Contributors/Factors
  • 14.3.1 Quantitative Growth Contributors
  • 14.3.2 Drivers
  • 14.3.3 Restraints

15 Global Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Total Addressable Market (TAM) Analysis

• 15.1 Definition And Scope of Total Addressable Market (TAM)
• 15.2 Methodology And Assumptions
  • 15.2.1 Total Addressable Market for the Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market - Business to Business (B2B)
  • 15.2.2 TAM Comparison Analysis

16 Global Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market Segmentation

• 16.1 Global Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.2 Global Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.3 Global Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.4 Global Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Sub-Segmentation Of Preclinical Or Clinical, By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.5 Global Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Sub-Segmentation Of Commercial, By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

17 Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Regional and Country Analysis

• 17.1 Global Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.2 Global Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

18 Asia-Pacific Market

• 18.1 Asia-Pacific Market Summary
• 18.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 18.3 Asia-Pacific Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.4 Asia-Pacific Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.5 Asia-Pacific Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.6 China Market
  • 18.6.1 China Market Summary
  • 18.6.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 18.6.3 China Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.6.4 China Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.6.5 China Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.7 India Market
  • 18.7.1 India Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.7.2 India Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.7.3 India Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.8 Japan Market
  • 18.8.1 Japan Market Summary
  • 18.8.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 18.8.3 Japan Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.8.4 Japan Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.8.5 Japan Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.9 Australia Market
  • 18.9.1 Australia Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.9.2 Australia Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.9.3 Australia Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.10 South Korea Market
  • 18.10.1 South Korea Market Summary
  • 18.10.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 18.10.3 South Korea Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.10.4 South Korea Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.10.5 South Korea Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.11 Taiwan Market
  • 18.11.1 Taiwan Market Summary
  • 18.11.2 Taiwan Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.11.3 Taiwan Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.11.4 Taiwan Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

19 South East Asia Market

• 19.1 South East Asia Market Summary
• 19.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 19.3 South East Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.4 South East Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.5 South East Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.6 Indonesia Market
  • 19.6.1 Indonesia Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.6.2 Indonesia Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.6.3 Indonesia Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

20 North America Market

• 20.1 North America Market Summary
• 20.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 20.3 North America Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.4 North America Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.5 North America Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.6 USA Market
  • 20.6.1 USA Market Summary
  • 20.6.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 20.6.3 USA Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.6.4 USA Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.6.5 USA Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.7 Canada Market
  • 20.7.1 Canada Market Summary
  • 20.7.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 20.7.3 Canada Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.7.4 Canada Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.7.5 Canada Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

21 Western Europe Market

• 21.1 Western Europe Market Summary
• 21.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 21.3 Western Europe Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.4 Western Europe Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.5 Western Europe Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.6 UK Market
  • 21.6.1 UK Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.6.2 UK Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.6.3 UK Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.7 Germany Market
  • 21.7.1 Germany Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.7.2 Germany Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.7.3 Germany Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.8 France Market
  • 21.8.1 France Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.8.2 France Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.8.3 France Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.9 Italy Market
  • 21.9.1 Italy Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.9.2 Italy Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.9.3 Italy Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.10 Spain Market
  • 21.10.1 Spain Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.10.2 Spain Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.10.3 Spain Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

22 South America Market

• 22.1 South America Market Summary
• 22.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 22.3 South America Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 22.4 South America Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 22.5 South America Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 22.6 Brazil Market
  • 22.6.1 Brazil Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 22.6.2 Brazil Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 22.6.3 Brazil Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

23 Eastern Europe Market

• 23.1 Eastern Europe Market Summary
• 23.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 23.3 Eastern Europe Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 23.4 Eastern Europe Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 23.5 Eastern Europe Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 23.6 Russia Market
  • 23.6.1 Russia Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 23.6.2 Russia Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 23.6.3 Russia Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

24 Middle East Market

• 24.1 Middle East Market Summary
• 24.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 24.3 Middle East Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 24.4 Middle East Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 24.5 Middle East Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

25 Africa Market

• 25.1 Africa Market Summary
• 25.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 25.3 Africa Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 25.4 Africa Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Synthesis Method, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 25.5 Africa Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Segmentation By Enterprise Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

26 Competitive Landscape And Company Profiles

• 26.1 Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market Competitive Landscape And & Market Share 2024
  • 26.1.1 Top 10 Companies (Ranked by revenue/share)
• 26.2 Company Profiles
• 26.3 Bachem Group (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 26.4 PolyPeptide Group (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 26.5 CordenPharma International GmbH (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 26.6 Ambiopharm Inc (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 26.7 Asymchem Laboratories (Tianjin) Co Ltd (Company Overview, Products and Services, Business Strategy, Financial Overview)

27 Other Major And Innovative Companies

• 27.1 Aspen Holdings (Aspen API) (Company Overview, Products and Services)
• 27.2 WuXi AppTec Co. Ltd. (Company Overview, Products and Services)
• 27.3 Piramal Pharma Solutions (PPS) (Company Overview, Products and Services)
• 27.4 GenScript Biotech Corporation (Company Overview, Products and Services)
• 27.5 ScinoPharm Taiwan Ltd. (Company Overview, Products and Services)
• 27.6 CEM Corporation (Company Overview, Products and Services)
• 27.7 Biosynth (Company Overview, Products and Services)
• 27.8 BioDuro LLC (Company Overview, Products and Services)
• 27.9 Hybio Pharmaceutical Co. Ltd. (Company Overview, Products and Services)
• 27.10 ChemPartner PharmaTech Co. Ltd. (Company Overview, Products and Services)
• 27.11 Cambrex Corporation (Company Overview, Products and Services)
• 27.12 Almac Group (Company Overview, Products and Services)
• 27.13 Syngene International Limited (Company Overview, Products and Services)
• 27.14 Chinese Peptide Company (CPC) (Company Overview, Products and Services)
• 27.15 Aurigene Pharmaceutical Services (Company Overview, Products and Services)

28 Competitive Benchmarking

29 Competitive Dashboard

30 USA Competitive Landscape And Company Profiles

• 30.1 Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market Competitive Landscape And & Market Share 2024
  • 30.1.1 Top 10 Companies (Ranked by revenue/share)

31 Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market - Company Scoring Matrix

• 31.1 Innovation & Brand Leaders
• 31.2 Brand-Driven Traditionalists
• 31.3 Niche or Regional Followers
• 31.4 Emerging Innovators

32 Upcoming Startups In the Market

33 Key Mergers And Acquisitions

• 33.1 Granules India Acquired Senn Chemicals
• 33.2 Novo Holdings Acquired Catalent
• 33.3 Cambrex Acquired Snapdragon Chemistry

34 Recent Developments In Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing

• 34.1 Scaling Global Peptide API Manufacturing Capacity Through Asia-Pacific Expansion
• 34.2 Strengthening Global Peptide API Supply Chains Through Strategic CDMO Collaboration

35 Opportunities And Strategies

• 35.1 Global Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market In 2030 - Countries Offering Most New Opportunities
• 35.2 Global Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market In 2030 - Segments Offering Most New Opportunities
• 35.3 Global Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36 Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Market, Conclusions And Recommendations

• 36.1 Conclusions
• 36.2 Recommendations
  • 36.2.1 Product
  • 36.2.2 Place
  • 36.2.3 Price
  • 36.2.4 Promotion
  • 36.2.5 People

37 Appendix

• 37.1 Geographies Covered
• 37.2 Market Data Sources
• 37.3 Research Methodology
• 37.4 Currencies
• 37.5 The Business Research Company
• 37.6 Copyright and Disclaimer